1185502-97-9 Usage
General Description
Aprepitant is a highly selective neurokinin 1 receptor antagonist that is used to prevent nausea and vomiting caused by chemotherapy and certain other medical treatments. It works by blocking the action of substance P, a neuropeptide that is involved in the regulation of emesis (vomiting). Aprepitant is often used in combination with other antiemetic medications to provide effective and long-lasting relief from chemotherapy-induced nausea and vomiting. It is available in oral and intravenous formulations and has been shown to be safe and well-tolerated, with minimal side effects in most patients. Overall, aprepitant is an important and effective medication for managing the distressing side effects of chemotherapy and improving the quality of life for cancer patients and others undergoing treatments that can cause severe nausea and vomiting.
Check Digit Verification of cas no
The CAS Registry Mumber 1185502-97-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,5,5,0 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1185502-97:
(9*1)+(8*1)+(7*8)+(6*5)+(5*5)+(4*0)+(3*2)+(2*9)+(1*7)=159
159 % 10 = 9
So 1185502-97-9 is a valid CAS Registry Number.
1185502-97-9Relevant articles and documents
Synthesis of the major isomers of Aprepitant and Fosaprepitant
Wan, Wei-Li,He, Yun,Guan, Mei,Li, Xiao-Long,Cheng, Xu,Wu, Yong
, p. 1118 - 1122 (2013)
The synthesis of two isomers of Aprepitant (APT) and three isomers of Fosaprepitant (FPT), crucial components for quality control in manufacturing, is described. Herein, three chiral centers in the isomers of Aprepitant are established in high yield by in
PREPARATION OF MORPHOLINE DERIVATIVES
-
, (2009/10/21)
This invention relates to processes and intermediates for the stereoselective morpholine derivatives. The invention in particular allows the stereoselective preparation of the drugs aprepitant and fosaprepitant.